• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤大小及其他影响胰头癌预后的因素。

Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas.

作者信息

Tsuchiya R, Oribe T, Noda T

出版信息

Am J Gastroenterol. 1985 Jun;80(6):459-62.

PMID:4003374
Abstract

Extent of the tumor in carcinoma of the pancreas seems an important factor in stage classification. The purpose of this report is to present the results of studies on the relationship between the size of the tumor (T) and prognosis, and the correlation between the size and the other factors influencing prognosis such as invasion to the pancreatic capsule, invasion to the retroperitoneal tissue, metastasis to the regional lymph node, and so on. T was divided into four groups: T1, T2, T3, T4. Tumor diameter of 2 cm or less was designated as T1, 2.1-4 cm as T2, 4.1-6 cm as T3, and 6.1 cm or more as T4. Case reports of 163 patients who underwent resection of carcinoma of the pancreatic head were submitted by 10 major institutions and retrospectively analyzed. There was significant differences in 1-year cumulative survival rates between T1 and T3, T1 and T4, and T1 and T2 + T3 + T4, but no significant difference in 3- or 5-year survival rates among the T groups. The incidence of no capsular invasion, no retroperitoneal invasion, and no lymph node metastasis had a tendency to decrease along with increase in tumor size and the incidence of definite capsular invasion, and lymph node metastases increase with increase in the size. Attempts to diagnose tumors of less than 2 cm should be made to ameliorate the poor surgical results. However, it should be stressed that even in the T1 group regional lymph node metastases were seen in about half of the cases.

摘要

胰腺癌中肿瘤的范围似乎是分期分类中的一个重要因素。本报告的目的是展示关于肿瘤大小(T)与预后之间关系的研究结果,以及肿瘤大小与其他影响预后的因素(如侵犯胰腺被膜、侵犯腹膜后组织、区域淋巴结转移等)之间的相关性。T分为四组:T1、T2、T3、T4。肿瘤直径2厘米及以下被指定为T1,2.1 - 4厘米为T2,4.1 - 6厘米为T3,6.1厘米及以上为T4。10个主要机构提交了163例行胰头癌切除术患者的病例报告并进行回顾性分析。T1与T3、T1与T4、T1与T2 + T3 + T4之间的1年累积生存率存在显著差异,但T组之间的3年或5年生存率无显著差异。无被膜侵犯、无腹膜后侵犯和无淋巴结转移的发生率有随肿瘤大小增加而降低的趋势,而明确的被膜侵犯和淋巴结转移的发生率则随肿瘤大小增加而升高。应尝试诊断小于2厘米的肿瘤以改善较差的手术结果。然而,应该强调的是,即使在T1组中,约一半的病例也可见区域淋巴结转移。

相似文献

1
Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas.肿瘤大小及其他影响胰头癌预后的因素。
Am J Gastroenterol. 1985 Jun;80(6):459-62.
2
[Surgical results and problems of pancreatic cancer].
Gan To Kagaku Ryoho. 1985 Feb;12(2):220-6.
3
Is tumor size a prognostic indicator for gastric carcinoma?肿瘤大小是胃癌的预后指标吗?
Anticancer Res. 2002 Nov-Dec;22(6B):3673-7.
4
The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size.直径小于4.0厘米的胰腺癌的淋巴及局部扩散方式。
Int Surg. 1993 Jul-Sep;78(3):208-12.
5
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.T1期乳腺癌患者肿瘤大小及腋窝淋巴结受累情况与预后的相关性
Cancer. 1998 Dec 15;83(12):2502-8.
6
Pancreatic head carcinoma: clinical analysis of 189 cases.胰头癌:189例临床分析
Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):79-84.
7
[Lymph node metastasis and prognosis in T1 and T2 rectal carcinoma].[T1和T2期直肠癌的淋巴结转移与预后]
Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):235-7.
8
Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.淋巴结转移在胰头癌外科治疗中的意义
J Exp Clin Cancer Res. 1999 Mar;18(1):23-8.
9
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
10
Metastatic potential in T1 and T2 colorectal cancer.T1和T2期结直肠癌的转移潜能
Hepatogastroenterology. 2005 Nov-Dec;52(66):1688-91.

引用本文的文献

1
Extended lymphadenectomy benefits patients with borderline resectable pancreatic head cancer-a single-center retrospective study.扩大淋巴结清扫术对临界可切除性胰头癌患者有益——一项单中心回顾性研究
Gland Surg. 2021 Oct;10(10):2910-2924. doi: 10.21037/gs-21-201.
2
Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.一种用于预测切除性胰腺腺癌患者预后的新型列线图的开发与验证
Oncol Lett. 2020 Jun;19(6):4093-4105. doi: 10.3892/ol.2020.11495. Epub 2020 Mar 29.
3
Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.
胰腺癌:80年的手术——百分比与重复情况
HPB Surg. 2016;2016:6839687. doi: 10.1155/2016/6839687. Epub 2016 Oct 25.
4
Pancreatic cancer--low survival rates.胰腺癌——存活率低。
Dtsch Arztebl Int. 2008 Apr;105(14):255-62. doi: 10.3238/arztebl.2008.0255. Epub 2008 Apr 4.
5
Analysis of long-term survivors after surgical resection for invasive pancreatic cancer.分析接受手术切除治疗的浸润性胰腺癌患者的长期生存情况。
HPB (Oxford). 2005;7(2):129-34. doi: 10.1080/13651820510003744.
6
Pancreatic carcinomas smaller than 3.0 cm: endosonography (EUS) in diagnosis, staging and prediction of resectability.
HPB (Oxford). 2003;5(4):226-30. doi: 10.1080/13651820310001342.
7
The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence.扩大淋巴结清扫术在胰头腺癌治疗中的作用:证据强度
J Gastrointest Surg. 2008 Apr;12(4):651-6. doi: 10.1007/s11605-007-0451-1. Epub 2007 Dec 18.
8
Extended radical operation of pancreatic head cancer: appraisal of its clinical significance.胰头癌扩大根治术:临床意义评估
World J Gastroenterol. 2005 Apr 28;11(16):2467-71. doi: 10.3748/wjg.v11.i16.2467.
9
Treatment of pancreatic cancer: challenge of the facts.胰腺癌的治疗:面对事实的挑战。
World J Surg. 2003 Oct;27(10):1075-84. doi: 10.1007/s00268-003-7165-7. Epub 2003 Aug 21.
10
Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.胰腺癌的新辅助治疗、辅助治疗及姑息治疗。
Curr Gastroenterol Rep. 2001 Apr;3(2):129-35. doi: 10.1007/s11894-001-0009-4.